GxP
Also known as: Good Practice regulations, GxP compliance
GxP is the collective name for the Good Practice regulations governing regulated life-sciences work — GMP for manufacturing, GCP for clinical trials, GLP for non-clinical safety studies, GDP for distribution — where the x stands in for the discipline.
What the x covers
| Regime | Scope | Anchor |
|---|---|---|
| GMP | Manufacture of drug substance and product | 21 CFR 210/211, EudraLex Vol. 4 |
| GCP | Design and conduct of clinical trials | ICH E6 |
| GLP | Non-clinical safety studies | 21 CFR 58, OECD GLP |
| GDP | Storage and distribution | EU GDP Guidelines |
| GVP | Pharmacovigilance | EU GVP Modules |
What they share
Each regime governs a different activity, but they rest on the same three ideas. Decisions must be documented well enough to be reconstructed years later by someone who was not there. Systems that produce regulated data must be validated. And the quality function must be able to say no without commercial override.
This is why GxP is useful as a single word: an organisation is rarely strong in one and weak in another by accident. The failures are cultural before they are technical.
Why it matters for software
A system is "GxP" not because of what it is but because of what it touches. A spreadsheet calculating a batch yield is in scope; the same spreadsheet tracking office supplies is not. Scope follows the predicate rule — the underlying regulation that requires the record to exist.
That determination drives everything downstream: validation effort, 21 CFR Part 11 controls, retention, and change management. Getting it wrong in either direction is costly. Over-scoping validates systems nobody needed to validate; under-scoping is a finding.
Go deeper
Related terms
Last reviewed 2026-08-05